Novartis’ CAR-T gene therapy, the first approved by FDA, to be priced based on cancer patients’ outcomes
August 30, 2017 at 11:54 AM EDT
The therapy is an innovative new cancer treatment that uses a patient’s immune system to better fight the disease.
